Reliance Global Group, Inc. (EZRA) Insider Trading

Last 12 months

Insiders bought $51k and sold $230k on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chief Financial Officer Joel Markovits sold $79k on Nov 26, 2025, 44% of their stake, outside a plan.

Net open-market

−$179k

1 buy · 6 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

1 / 4

executives and directors

Last open-market buy

Mar 2026

Mar 26, 2026

Get an email when EZRA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 3	Joel Markovits Chief Financial Officer	SoldNo plan	9,329	$2.55	$24k	100%	Form 4
Aug 3	Alex Blumenfrucht Director	SoldNo plan	8,830	$3.97	$35k	100%	Form 4
Aug 3	Yaakov Beyman Exec VP, Insurance Division	SoldNo plan 2 parts	9,120	$3.84 average	$35k	75%	Form 4
Aug 3	Ben Fruchtzweig Director	SoldNo plan	7,448	$4.08	$30k	100%	Form 4
Mar 26	Ezra Beyman Chairman and CEO	Bought	300,000	$0.17	$51k	45%	Form 4
Mar 24	Joel Markovits Chief Financial Officer	SoldNo plan	127,562	$0.21	$27k	100%	Form 4
Sep 3, 2025 – Nov 26, 2025	Joel Markovits Chief Financial Officer	SoldNo plan 4 parts	99,492	$0.80 average	$79k	44%	Form 4
Jun 18, 2025	Ben Fruchtzweig Director	SoldNo plan	26,000	$2.85	$74k	23%	Form 4
Jun 18, 2025	Sheldon Brickman Director	SoldNo plan	15,236	$2.82	$43k	12%	Form 4
Jun 18, 2025	Joel Markovits Chief Financial Officer	SoldNo plan	40,534	$3.00	$122k	10%	Form 4
Jun 18, 2025	Alex Blumenfrucht Director	SoldNo plan	36,249	$2.90	$105k	35%	Form 4
Jun 18, 2025	Yaakov Beyman EXEC VP, INSURANCE DIVISION	SoldNo plan 2 parts	20,000	$3.06 average	$61k	7.4%	Form 4
Dec 23, 2024	Yaakov Beyman Exec VP, Insurance Division	SoldNo plan	3,001	$3.80	$11k	31%	Form 4
Dec 23, 2024	Alex Blumenfrucht Director	SoldNo plan	5,236	$3.69	$19k	92%	Form 4
Nov 22, 2024	Joel Markovits Chief Financial Officer	SoldNo plan	10,603	$1.37	$15k	5.0%	Form 4

Aug 3No plan
Joel Markovits
Chief Financial Officer · sold 9,329 at $2.55
$24k
100% of stake
Aug 3No plan
Alex Blumenfrucht
Director · sold 8,830 at $3.97
$35k
100% of stake
Aug 3No plan
Yaakov Beyman
Exec VP, Insurance Division · sold 9,120 at avg $3.84
$35k
75% of stake
Aug 3No plan
Ben Fruchtzweig
Director · sold 7,448 at $4.08
$30k
100% of stake
Mar 26
Ezra Beyman
Chairman and CEO · bought 300,000 at $0.17
$51k
45% of stake
Mar 24No plan
Joel Markovits
Chief Financial Officer · sold 127,562 at $0.21
$27k
100% of stake
Sep 3, 2025 – Nov 26, 2025No plan
Joel Markovits
Chief Financial Officer · sold 99,492 at avg $0.80
$79k
44% of stake
Jun 18, 2025No plan
Ben Fruchtzweig
Director · sold 26,000 at $2.85
$74k
23% of stake
Jun 18, 2025No plan
Sheldon Brickman
Director · sold 15,236 at $2.82
$43k
12% of stake
Jun 18, 2025No plan
Joel Markovits
Chief Financial Officer · sold 40,534 at $3.00
$122k
10% of stake
Jun 18, 2025No plan
Alex Blumenfrucht
Director · sold 36,249 at $2.90
$105k
35% of stake
Jun 18, 2025No plan
Yaakov Beyman
EXEC VP, INSURANCE DIVISION · sold 20,000 at avg $3.06
$61k
7.4% of stake
Dec 23, 2024No plan
Yaakov Beyman
Exec VP, Insurance Division · sold 3,001 at $3.80
$11k
31% of stake
Dec 23, 2024No plan
Alex Blumenfrucht
Director · sold 5,236 at $3.69
$19k
92% of stake
Nov 22, 2024No plan
Joel Markovits
Chief Financial Officer · sold 10,603 at $1.37
$15k
5.0% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch EZRA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Insurance Agents, Brokers & Service

QDMIQDM International Inc.

HITHealth In Tech Inc.

RDZNRoadzen Inc.

AIFUAIFU Inc.

Spot a number that looks wrong? Check it in EZRA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing EZRA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.